Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Howick

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
The American Journal of Bioethics : AJOB|March 16, 2012
Saying things the "right" way: avoiding "nocebo" effects and providing full informed consentJeremy Howick
The American Journal of Bioethics : AJOB|December 10, 2009
Reviewing the unsubstantiated claims for the methodological superiority of 'placebo' over 'active' controlled trials: reply to open peer commentariesJeremy Howick
The American Journal of Bioethics : AJOB|January 31, 2009
If children understand drawing straws and flipping coins, research participants can understand randomizationJeremy Howick
Perspectives in Biology and Medicine|April 30, 2019
Exploring the Asymmetrical Relationship Between the Power of Finance Bias and EvidenceJeremy Howick
BMJ (Clinical Research Ed.)|May 14, 2009
Placebo misery. Escaping from placebo prisonJeremy Howick
The American Journal of Bioethics : AJOB|December 10, 2009
Questioning the methodologic superiority of 'placebo' over 'active' controlled trialsJeremy Howick
Journal of Medical Ethics|February 18, 2020
Unethical informed consent caused by overlooking poorly measured nocebo effectsJeremy Howick
Internal and Emergency Medicine|October 11, 2019
Why include humanities in medical studies: commentJeremy Howick
Journal of the Royal Society of Medicine|June 5, 2019
Did John Stuart Mill influence the design of controlled clinical trials?Roger Bailey, Jeremy Howick
BMJ (Clinical Research Ed.)|June 5, 2023
On the ethical requirement to inform patients about potential treatment benefitsJeremy Howick, Peter Doshi
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
The American Journal of Bioethics : AJOB|March 16, 2012
Saying things the "right" way: avoiding "nocebo" effects and providing full informed consentJeremy Howick
The American Journal of Bioethics : AJOB|December 10, 2009
Reviewing the unsubstantiated claims for the methodological superiority of 'placebo' over 'active' controlled trials: reply to open peer commentariesJeremy Howick
The American Journal of Bioethics : AJOB|January 31, 2009
If children understand drawing straws and flipping coins, research participants can understand randomizationJeremy Howick
Perspectives in Biology and Medicine|April 30, 2019
Exploring the Asymmetrical Relationship Between the Power of Finance Bias and EvidenceJeremy Howick
BMJ (Clinical Research Ed.)|May 14, 2009
Placebo misery. Escaping from placebo prisonJeremy Howick
The American Journal of Bioethics : AJOB|December 10, 2009
Questioning the methodologic superiority of 'placebo' over 'active' controlled trialsJeremy Howick
Journal of Medical Ethics|February 18, 2020
Unethical informed consent caused by overlooking poorly measured nocebo effectsJeremy Howick
Internal and Emergency Medicine|October 11, 2019
Why include humanities in medical studies: commentJeremy Howick
Journal of the Royal Society of Medicine|June 5, 2019
Did John Stuart Mill influence the design of controlled clinical trials?Roger Bailey, Jeremy Howick
BMJ (Clinical Research Ed.)|June 5, 2023
On the ethical requirement to inform patients about potential treatment benefitsJeremy Howick, Peter Doshi
Pageof 14